We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Le produit de thérapie génique SENS-501 et la procédure chirurgicale sont bien tolérés par les deux premiers patients traités et des évolutions comportementales encourageantes sont observées...
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...
Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...
Sensorion to host a webconference dedicated to its retail shareholders on October 10, 2024, in French, at 6pm CET (12pm ET) Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.074 | -10.7246376812 | 0.69 | 0.69 | 0.594 | 50633 | 0.63963178 | DE |
4 | -0.004 | -0.645161290323 | 0.62 | 0.77 | 0.584 | 42699 | 0.66902089 | DE |
12 | -0.144 | -18.9473684211 | 0.76 | 0.814 | 0.584 | 36844 | 0.69880102 | DE |
26 | -0.084 | -12 | 0.7 | 0.97 | 0.584 | 41732 | 0.75967287 | DE |
52 | 0.1865 | 43.4225844005 | 0.4295 | 1.04 | 0.406 | 63517 | 0.73964964 | DE |
156 | -1.196 | -66.004415011 | 1.812 | 2.29 | 0.26 | 77506 | 0.69489458 | DE |
260 | -0.319 | -34.1176470588 | 0.935 | 2.665 | 0.26 | 84579 | 1.11693238 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions